- Hem
- Om universitetet
- Hitta person
- Marcus Lind
Marcus Lind
Om Marcus Lind
Läs mer om Marcus Lind och hans forskning (på engelska) här.
-
Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin
Glargine
Donald C. Simonson, Marcia A. Testa, Ella Ekholm, Maxwell Su, Tina Vilsboll, Serge A. Jabbour, Marcus Lind
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM - 2024 -
The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover
trial
Sofia Sterner Isaksson, Arndis Olafsdottir, Simon Ivarsson, Henrik Imberg, Eva Toft, Sara Hallström, Ulf Rosenqvist, Marie Ekstrom, Marcus Lind
LANCET REGIONAL HEALTH-EUROPE - 2024 -
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD
8)
T. Nyström, E. Schwarz, Sofia Dahlqvist, M. Wijkman, M. Ekelund, H. Holmer, J. Bolinder, J. Hellman, Henrik Imberg, I. B. Hirsch, Marcus Lind
Journal of Diabetes Science and Technology - 2024 -
Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide
Study.
Eleftheria Gkaniatsa, Tatiana Zverkova Sandström, Annika Rosengren, Penelope Trimpou, Daniel S Olsson, Marcus Lind, Andreas Muth, Gudmundur Johannsson, Oskar Ragnarsson
Hypertension (Dallas, Tex. : 1979) - 2023 -
Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database
Study
Marcus Lind, S. B. Catrina, N. R. Ekberg, S. Gerward, T. Halasa, J. Hellman, D. Hess, M. Londahl, V. Qvist, J. Bolinder
Diabetes Therapy - 2023 -
Investigating immune profile by CyTOF in individuals with long-standing type 1
diabetes
Helen Larsson, Sofie Albinsson, Marcus Lind, Hardis Rabe, Christine Lingblom
SCIENTIFIC REPORTS - 2023 -
Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1
diabetes
Sofia Sterner Isaksson, Arndís F. Ólafsdóttir, Marcus Lind
Frontiers in Nutrition - 2023 -
Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized
Trial
Daniel Pylov, W. Polonsky, Henrik Imberg, H. Holmer, J. Hellman, M. Wijkman, J. Bolinder, T. Heisse, S. Dahlqvist, T. Nystrom, E. Schwarz, I. Hirsch, Marcus Lind
Journal of Diabetes Science and Technology - 2023 -
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data &
TRADE
E. M. Tallon, M. P. Gallagher, V. S. Staggs, D. Ferro, D. B. Murthy, O. Ebekozien, M. N. Kosiborod, Marcus Lind, C. Manrique-Acevedo, C. R. Shyu, M. A. Clements
Bmj Open - 2023 -
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in
Sweden.
Jon Edqvist, Christina Lundberg, Karin Andréasson , Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Diabetes care - 2023 -
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the
UK
A. Gonzalez Perez, D. Vizcaya, M. E. Sáez, Marcus Lind, L. A. Garcia Rodriguez
BMJ open diabetes research & care - 2023 -
Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical
trial
Arndís F. Ólafsdóttir, Marcus Lind
Frontiers in Clinical Diabetes and Healthcare - 2023 -
Glycaemic control and sepsis risk in adults with type 1
diabetes
A. Balintescu, Marcus Lind, M. A. Franko, A. Oldner, M. Cronhjort, B. Eliasson, C. Svensen, J. Martensson
Diabetes Obesity & Metabolism - 2023 -
Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled
Trial
R. Gabriel, N. Boukichou-Abdelkader, A. Gilis-Januszewska, K. Makrilakis, R. Gomez-Huelgas, Z. Kamenov, B. Paulweber, I. Satman, P. Djordjevic, A. Alkandari, A. Mitrakou, N. Lalic, J. Egido, S. Mas-Fontao, J. H. Calvet, J. C. Pastor, J. Lindstrom, Marcus Lind, T. Acosta, L. Silva, J. Tuomilehto
Journal of Clinical Medicine - 2023 -
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort
study
A. Zabala, A. Gottsaeter, Marcus Lind, Björn Eliasson, R. Bertilsson, J. Ekelund, M. Jonsson, T. Nystroem
Diabetes & Vascular Disease Research - 2023 -
Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational
study
W. Linn, M. Persson, B. Rathsman, J. Ludvigsson, Marcus Lind, M. A. Franko, T. Nystrom
Cardiovascular Diabetology - 2023 -
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study
protocol
J. Ludvigsson, L. Eriksson, C. Nowak, P. F. Teixeira, M. Widman, A. Lindqvist, R. Casas, Marcus Lind, U. Hannelius
Bmj Open - 2022 -
Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney
disease
Arndis Olafsdottir, M. Andelin, Aso Saeed, S. Sofizadeh, H. Hamoodi, Per-Anders Jansson, Marcus Lind
World Journal of Clinical Cases - 2022 -
Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2
Diabetes
A. Balintescu, Marcus Lind, M. A. Franko, A. Oldner, M. Cronhjort, Ann-Marie Svensson, Björn Eliasson, J. Mårtensson
Diabetes Care - 2022 -
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician
Ratings
D. C. Klonoff, J. Wang, D. Rodbard, M. A. Kohn, C. Li, D. Liepmann, D. Kerr, D. Ahn, A. L. Peters, G. E. Umpierrez, J. J. Seley, N. Y. Xu, K. T. Nguyen, G. Simonson, M. S. D. Agus, M. E. Al-Sofiani, G. Armaiz-Pena, T. S. Bailey, A. Basu, T. Battelino, S. Y. Bekele, P. Y. Benhamou, B. W. Bequette, T. Blevins, M. D. Breton, J. R. Castle, J. G. Chase, K. Y. Chen, P. Choudhary, M. A. Clements, K. L. Close, C. B. Cook, T. Danne, III Doyle, A. Drincic, K. M. Dungan, S. V. Edelman, N. Ejskjaer, J. C. Espinoza, G. A. Fleming, G. P. Forlenza, G. Freckmann, R. J. Galindo, A. M. Gomez, H. A. Gutow, L. Heinemann, I. B. Hirsch, T. D. Hoang, R. Hovorka, J. H. Jendle, L. Ji, S. R. Joshi, M. Joubert, S. K. Koliwad, R. A. Lal, M. C. Lansang, W. A. Lee, L. Leelarathna, L. A. Leiter, Marcus Lind, M. L. Litchman, J. K. Mader, K. M. Mahoney, B. Mankovsky, U. Masharani, N. N. Mathioudakis, A. Mayorov, J. Messler, J. D. Miller, V. Mohan, J. H. Nichols, K. Nørgaard, D. N. O’Neal, F. J. Pasquel, A. Philis-Tsimikas, T. Pieber, M. Phillip, W. H. Polonsky, R. Pop-Busui, G. Rayman, E. J. Rhee, S. J. Russell, V. N. Shah, J. L. Sherr, K. Sode, E. K. Spanakis, D. J. Wake, K. Waki, A. Wallia, M. E. Weinberg, H. Wolpert, E. E. Wright, M. Zilbermint, B. Kovatchev
Journal of Diabetes Science and Technology - 2022 -
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin
injections
Klara Westman, Henrik Imberg, M. O. Wijkman, I. B. Hirsch, J. Tuomilehto, Sofia Dahlqvist, Marcus Lind
Journal of Diabetes and its Complications - 2022 -
Body mass index in adolescence, risk of type 2 diabetes and associated complications: A nationwide cohort study of
men
Karin Andréasson , Jon Edqvist, Martin Adiels, Lena Björck, Martin Lindgren, S. Naveed, Marcus Lind, Maria A I Åberg, Annika Rosengren
EClinicalMedicine - 2022 -
Intralymphatic GAD-Alum (Diamyd (R)) Improves Glycemic Control in Type 1 Diabetes With HLA
DR3-DQ2
C. Nowak, Marcus Lind, Z. Sumnik, T. Pelikanova, L. N. Chavez, E. Lundberg, I. Rica, M. A. Martinez-Brocca, M. S. R. de Adana, J. Wahlberg, R. Hanas, C. Hernandez, M. Clemente-Leon, A. Gomez-Gila, M. F. Lozano, T. Sas, S. Pruhova, F. Dietrich, S. P. Marin, U. Hannelius, R. Casas, J. Ludvigsson
Journal of Clinical Endocrinology & Metabolism - 2022 -
Risk factors for nephropathy in persons with type 1 diabetes: a population-based
study
Shilan Seyed Ahmadi, Aldina Pivodic, A. M. Svensson, Hans Wedel, B. Rathsman, T. Nystrom, J. Ludvigsson, Marcus Lind
Acta Diabetologica - 2022 -
Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: A Swedish observational cohort
study
Sara Hallström, M. O. Wijkman, J. Ludvigsson, P. Ekman, M. A. Pfeffer, Hans Wedel, Annika Rosengren, Marcus Lind
Lancet Regional Health-Europe - 2022 -
LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort
study
B. Rathsman, J. Haas, M. Persson, J. Ludvigsson, Ann-Marie Svensson, Marcus Lind, M. A. Franko, T. Nystrom
Journal of Internal Medicine - 2021 -
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial
(GOLD-5)
Arndis Olafsdottir, J. Bolinder, T. Heise, W. Polonsky, M. Ekelund, M. Wijkman, Aldina Pivodic, Elsa Ahlén, E. Schwarcz, T. Nystrom, J. Hellman, I. B. Hirsch, Marcus Lind
Diabetes Obesity & Metabolism - 2021 -
Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1
Diabetes
Mary Dena, Ann-Marie Svensson, Katarina Eeg-Olofsson, L. Young, A. Carlson, K. Miller, J. Grimsmann, R. Welp, J. K. Mader, D. M. Maahs, R. W. Holl, Marcus Lind
Diabetes Therapy - 2021 -
Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and
Prediabetes
Sheyda Sofizadeh, A. Pehrsson, Arndis Olafsdottir, Marcus Lind
Journal of Diabetes Science and Technology - 2021 -
Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS
88
Marcus Lind, Henrik Imberg, Ruth L. Coleman, Olle Nerman, Rury R. Holman
Diabetes Care - 2021 -
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at
onset
Jon Edqvist, Araz Rawshani, Aidin Rawshani, Martin Adiels, S. Franzén, Lena Björck, A. M. Svensson, Marcus Lind, N. Sattar, Annika Rosengren
BMJ Open Diabetes Research and Care - 2021 -
Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin
injections
Klara Westman, Henrik Imberg, H. Albrektsson, I. B. Hirsch, J. Tuomilehto, Sofia Dahlqvist, Marcus Lind
Primary Care Diabetes - 2021 -
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort
study.
Aidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, Naveed Sattar, Katarina Eeg-Olofsson, Martin Adiels, Johnny Ludvigsson, Marcus Lind, Magnus Gisslén, Eva Hagberg, Georg Lappas, Björn Eliasson, Annika Rosengren
The Lancet regional health. Europe - 2021 -
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With
MDI
Marcus Lind, Arndis Olafsdottir, I. B. Hirsch, J. Bolinder, Sofia Dahlqvist, Aldina Pivodic, J. Hellman, M. Wijkman, E. Schwarcz, H. Albrektsson, T. Heise, W. Polonsky
Diabetes Care - 2021 -
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes
Registry
Sara Hallström, Ann-Marie Svensson, Aldina Pivodic, Arndis Olafsdottir, M. Londahl, Hans Wedel, Marcus Lind
Diabetologia - 2021 -
Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort
study
A. Zabala, A. Gottsater, Marcus Lind, Ann-Marie Svensson, Björn Eliasson, R. Bertilsson, J. Ekelund, T. Nystrom, M. Jonsson
Cardiovascular Diabetology - 2021 -
Prevalence and impact of chronic dysglycemia in intensive care unit patients-A retrospective cohort
study
A. Balintescu, I. Palmgren, M. Lipcsey, A. Oldner, A. Larsson, M. Cronhjort, Marcus Lind, J. Wernerman, J. Martensson
Acta Anaesthesiologica Scandinavica - 2021 -
Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized
trial
Sofia Sterner Isaksson, Margareta Bensow Bacos, Björn Eliasson, E. T. Adolfsson, Araz Rawshani, Ulf Lindblad, J. Jendle, Agneta Berglund, Marcus Lind, Mette Axelsen
Bmj Open Diabetes Research & Care - 2021 -
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: A population-based cohort study in the
UK
A. González-Pérez, M. Saez, D. Vizcaya, Marcus Lind, L. Garcia Rodriguez
BMJ Open Diabetes Research and Care - 2021 -
Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort
study
A. Zabala, V. Darsalia, Marcus Lind, Ann-Marie Svensson, S. Franzen, Björn Eliasson, C. Patrone, M. Jonsson, T. Nystrom
Cardiovascular Diabetology - 2021 -
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb
Trial
J. Ludvigsson, Z. Sumnik, T. Pelikanova, L. N. Chavez, E. Lundberg, I. Rica, M. A. Martinez-Brocca, M. R. de Adana, J. Wahlberg, A. Katsarou, R. Hanas, C. Hernandez, M. C. Leon, A. Gomez-Gila, Marcus Lind, M. F. Lozano, T. Sas, U. Samuelsson, S. Pruhova, F. Dietrich, S. P. Marin, A. Nordlund, U. Hannelius, R. Casas
Diabetes Care - 2021 -
Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin
Injections
Sara Hallström, I. B. Hirsch, M. Ekelund, S. Sofizadeh, H. Albrektsson, S. Dahlqvist, Ann-Marie Svensson, Marcus Lind
Diabetes Technology & Therapeutics - 2021 -
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and-2
studies
M. Phillip, C. Mathieu, Marcus Lind, E. Araki, P. di Bartolo, R. Bergenstal, S. Heller, L. Hansen, M. F. Scheerer, F. Thoren, N. Arya, J. Xu, N. Iqbal, P. Dandona
Diabetes Obesity & Metabolism - 2021 -
Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United
Kingdom.
Antonio González-Pérez, Maria E Saéz, David Vizcaya, Marcus Lind, Luis A García Rodríguez
Primary care diabetes - 2020 -
The Association Between HbA(1c)and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial
(GOLD-4)
Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic, Arndis Olafsdottir, S. Dahlqvist, I. B. Hirsch, J. Hellman, M. Ekelund, T. Heise, W. Polonsky, M. Wijkman, E. Schwarcz, Marcus Lind
Diabetes care - 2020 -
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3
trial
T. Vilsboll, E. Ekholm, E. Johnsson, R. Garcia-Sanchez, N. Dronamraju, S. A. Jabbour, Marcus Lind
Diabetes, obesity and metabolism - 2020 -
Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort
study
Shilan Seyed Ahmadi, Ann-Marie Svensson, Aldina Pivodic, Annika Rosengren, Marcus Lind
Cardiovascular Diabetology - 2020 -
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled
trial
C. Mathieu, G. Rudofsky, M. Phillip, E. Araki, Marcus Lind, N. Arya, F. Thoren, M. F. Scheerer, N. Iqbal, P. Dandona
Diabetes Obesity & Metabolism - 2020 -
Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With
Diabetes
C. S. Cabrera, A. S. Lee, Marita Olsson, V. Schnecke, Klara Westman, Marcus Lind, P. J. Greasley, Stanko Skrtic
Kidney International Reports - 2020 -
Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: Amputations and type 1
diabetes
Arndis Olafsdottir, Ann-Marie Svensson, A. Pivodic, Soffia Gudbjörnsdottir, T. Nyström, Hans Wedel, Annika Rosengren, Marcus Lind
BMJ Open Diabetes Research and Care - 2019 -
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin
Injections.
Sheyda Sofizadeh, Henrik Imberg, Arndis Olafsdottir, Magnus Ekelund, Sofia Dahlqvist, Irl Hirsch, Karin Filipsson, Bo Ahrén, Stefan Sjöberg, Jaako Tuomilehto, Marcus Lind
Diabetes therapy : research, treatment and education of diabetes and related disorders - 2019 -
Glycaemic control and excess risk of major coronary events in patients with type 2 diabetes: a population-based
study.
Mauro Tancredi, Annika Rosengren, Ann-Marie Svensson, Aldina Pivodic, Soffia Gudbjörnsdottir, Hans Wedel, Marcus Lind
Open heart - 2019 -
Use of fast-acting insulin aspart in insulin pump therapy in clinical
practice
M. Evans, A. Ceriello, T. Danne, C. De Block, J. H. DeVries, Marcus Lind, C. Mathieu, K. Nørgaard, E. Renard, E. G. Wilmot
Diabetes, Obesity and Metabolism - 2019 -
Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial
Infarction.
Thomas Nyström, Ulrik Sartipy, Andrea Contardi, Marcus Lind, Rino Bellocco, Björn Eliasson, Ann-Marie Svensson, Martin J Holzmann
Circulation - 2019 -
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study
5).
Shilan Seyed Ahmadi, K Filipsson, H Dimenäs, Sofia Sterner Isaksson, H Imberg, S Sjöberg, B Ahrén, S Dahlqvist, T Gustafsson, J Tuomilehto, I B Hirsch, Marcus Lind
Obesity science & practice - 2019 -
Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2
diabetes.
Magnus O Wijkman, Mary Dena, Sofia Dahlqvist, Sheyda Sofizadeh, Irl Hirsch, Jaakko Tuomilehto, Johan Mårtensson, Ole Torffvit, Henrik Imberg, Aso Saeed, Marcus Lind
Journal of clinical hypertension (Greenwich, Conn.) - 2019 -
Contrasting Associations of Body Mass Index and Hemoglobin A1c on the Excess Risk of Acute Myocardial Infarction and Heart Failure in Type 2 Diabetes
Mellitus.
Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, Ann-Marie Svensson, Soffia Gudbjörnsdottir, Naveed Sattar, Annika Rosengren
Journal of the American Heart Association - 2019 -
HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort
study
Marcus Lind, A. Pivodic, Ann-Marie Svensson, Arndis Olafsdottir, Hans Wedel, J. Ludvigsson
Bmj-British Medical Journal - 2019 -
Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes
Registry
Sara Hallström, Aldina Pivodic, Annika Rosengren, Arndis Olafsdottir, Ann-Marie Svensson, Marcus Lind
Diabetes Care - 2019 -
BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity
Paradox
Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, A. M. Svensson, S. Gudbjornsdottir, N. Sattar, Annika Rosengren
Diabetes Care - 2019 -
Investigation of early signs of systolic and diastolic dysfunction among persons with type 1
diabetes
Daniel Vestberg, Magnus C Johansson, A. Letho, A. Pivodic, S. Hallström, Arndis Olafsdottir, Annika Rosengren, Marcus Lind
Open Heart - 2019 -
Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1
and-2
C. Mathieu, P. Dandona, M. Phillip, T. Oron, Marcus Lind, L. Hansen, F. Thoren, J. Xu, A. M. Langkilde, Depict- Investigators; DEPICT-2 Investigators Depict- Investigators; DEPICT-2 Investigators
Diabetes Care - 2019 -
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical
Trial
T. Vilsboll, E. Ekholm, E. Johnsson, N. Dronamraju, S. Jabbour, Marcus Lind
Diabetes Care - 2019 -
BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General
Population
Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, A. M. Svensson, S. Gudbjornsdottir, N. Sattar, Annika Rosengren
Diabetes Care - 2018 -
Excess risk of hospitalisation for heart failure among people with type 2
diabetes
Annika Rosengren, Jon Edqvist, Araz Rawshani, N. Sattar, S. Franzen, Martin Adiels, A. M. Svensson, Marcus Lind, Soffia Gudbjörnsdottir
Diabetologia - 2018 -
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial
3)
S. Dahlqvist, Elsa Ahlén, K. Filipsson, T. Gustafsson, I. B. Hirsch, J. Tuomilehto, Henrik Imberg, B. Ahrén, Stig Attvall, Marcus Lind
BMC Open Diabetes Research and Care - 2018 -
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled
Trial
C. Mathieu, P. Dandona, P. Gillard, P. Senior, C. Hasslacher, E. Araki, Marcus Lind, S. C. Bain, S. Jabbour, N. Arya, L. Hansen, F. Thoren, A. M. Langkilde
Diabetes Care - 2018 -
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections
(GOLD-3)
Arndis Olafsdottir, W. Polonsky, J. Bolinder, I. B. Hirsch, Hans Wedel, T. Nystrom, M. Wijkman, E. Schwarcz, J. Hellman, T. Heise, Marcus Lind
Diabetes Technology & Therapeutics - 2018 -
Body mass index as a risk factor for coronary events and mortality in patients with type 1
diabetes
Daniel Vestberg, Annika Rosengren, Katarina Eeg-Olofsson, M. Miftaraj, S. Franzen, A. M. Svensson, Marcus Lind
Open Heart - 2018 -
Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control
study
S. Dahlqvist, Annika Rosengren, Soffia Gudbjörnsdottir, A. Pivodic, Hans Wedel, M. Kosiborod, A. M. Svensson, Marcus Lind
Lancet Diabetes & Endocrinology - 2017 -
Glycaemic control and excess risk of major coronary events in persons with type 1
diabetes
Viktorija Matuleviciene Anängen, Annika Rosengren, A. M. Svensson, A. Pivodic, Soffia Gudbjörnsdottir, Hans Wedel, M. Kosiborod, Börje Haraldsson, Marcus Lind
Heart - 2017 -
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical
Trial
Marcus Lind, W. Polonsky, I. B. Hirsch, T. Heise, J. Bolinder, S. Dahlqvist, E. Schwarz, A. F. Olafsdottir, A. Frid, Hans Wedel, Elsa Ahlén, T. Nystrom, J. Hellman
Jama-Journal of the American Medical Association - 2017 -
Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2
diabetes.
Stanko Skrtic, Claudia Cabrera, Marita Olsson, Volker Schnecke, Marcus Lind
Heart (British Cardiac Society) - 2017 -
A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1
Diabetes
Arndis Olafsdottir, Stig Attvall, U. Sandgren, S. Dahlqvist, A. Pivodic, Stanko Skrtic, E. Theodorsson, Marcus Lind
Diabetes Technology & Therapeutics - 2017 -
Prevalence of primary aldosteronism among patients with type 2
diabetes.
Mauro Tancredi, Gudmundur Johannsson, Björn Eliasson, Robert Eggertsen, Ulf Lindblad, S Dahlqvist, Henrik Imberg, Marcus Lind
Clinical endocrinology - 2017 -
Risk factors for diabetic macular oedema in type 2 diabetes: A case-control study in a United Kingdom primary care
setting
E. Martin-Merino, J. Fortuny, E. Rivero-Ferrer, Marcus Lind, L. A. Garcia-Rodriguez
Prim Care Diabetes - 2017 -
Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in
Sweden
P. Moström, Elsa Ahlén, Henrik Imberg, Per-Olof Hansson, Marcus Lind
BMJ Open Diabetes Research and Care - 2017 -
Long-term excess risk of stroke in people with Type 2 diabetes in Sweden according to blood pressure level: a population-based case-control
study
Christina Hedén Ståhl, Marcus Lind, A. M. Svensson, M. Kosiborod, Soffia Gudbjörnsdottir, A. Pivodic, M. Clements, Annika Rosengren
Diabetic medicine : a journal of the British Diabetic Association - 2017 -
Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a
Reference.
Mervi Andelin, Jort Kropff, Viktorija Matuleviciene, Jeffrey I Joseph, Stig Attvall, Elvar Theodorsson, Irl B Hirsch, Henrik Imberg, Sofia Dahlqvist, David Klonoff, Börje Haraldsson, J Hans DeVries, Marcus Lind
Journal of diabetes science and technology - 2016 -
Changes in HbA(1c) and circulating and adipose tissue androgen levels in overweight-obese women with polycystic ovary syndrome in response to
electroacupuncture
Elisabet Stener-Victorin, M. Maliqueo, M. Soligo, V. Protto, L. Manni, Elisabeth Jerlhag, Milana Kokosar, Antonina Sazonova, Carl Johan Behre, Marcus Lind, Claes Ohlsson, K. Hojlund, Anna Benrick
Obesity Science & Practice - 2016 -
Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet
therapy
A. Grodzinsky, S. V. Arnold, T. Y. Wang, P. Sharma, K. Gosch, P. G. Jones, D. L. Bhatt, P. G. Steg, D. K. McGuire, D. J. Cohen, J. A. Spertus, A. K. Chhatriwalla, Marcus Lind, G. Graham, M. Kosiborod
American Heart Journal - 2016 -
High hemoglobin A1c variability is associated with early risk of microalbuminuria in children with
T1D
S. Raman, H. Dai, S. A. DeLurgio, D. D. Williams, Marcus Lind, S. R. Patton, J. A. Spertus, M. Kosiborod, M. A. Clements
Pediatric diabetes - 2016 -
Glycemic control, renal complications, and current smoking in relation to excess risk of mortality in persons with type 1
diabetes
Elsa Ahlén, A. Pivodic, Hans Wedel, S. Dahlqvist, M. Kosiborod, Marcus Lind
Journal of Diabetes Science and Technology - 2016 -
The relationship between eGFR and hospitalization for heart failure in 54,486 individuals with type 2
diabetes
Mauro Tancredi, Annika Rosengren, Marita Olsson, Soffia Gudbjörnsdottir, A. M. Svensson, Börje Haraldsson, Marcus Lind
DIABETES-METABOLISM RESEARCH AND REVIEWS - 2016 -
Excess Mortality among Persons with Type 2
Diabetes
Marcus Lind, Hans Wedel, Annika Rosengren
The New England journal of medicine - 2016 -
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD
Study).
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Nils-Gunnar Pehrsson, Peter Moström
Journal of diabetes science and technology - 2016 -
Risk factors for diabetic retinopathy in people with Type 2 diabetes: A case-control study in a UK primary care
setting
E. Martin-Merino, J. Fortuny, E. Rivero-Ferrer, Marcus Lind, L. A. Garcia-Rodriguez
Primary Care Diabetes - 2016 -
Decreased eGFR as a Risk Factor for Heart Failure in 13 781 Individuals With Type 1
Diabetes.
Daniel Vestberg, Annika Rosengren, Marita Olsson, Soffia Gudbjörnsdottir, Börje Haraldsson, Ann-Marie Svensson, Marcus Lind
Journal of diabetes science and technology - 2016 -
Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control
study.
Annika Rosengren, Daniel Vestberg, Ann-Marie Svensson, Mikhail Kosiborod, Mark Clements, Araz Rawshani, Aldina Pivodic, Soffia Gudbjörnsdottir, Marcus Lind
The lancet. Diabetes & endocrinology - 2015 -
Glycemic control and excess mortality in type 1
diabetes
Marcus Lind, A. M. Svensson, Annika Rosengren
The New England journal of medicine - 2015 -
Contemporary Risk Estimates of Three HbA(1c) Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2
Diabetes
Marita Olsson, V. Schnecke, C. Cabrera, Stanko Skrtic, Marcus Lind
Diabetes Care - 2015 -
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide
trial).
Marcus Lind, Irl B Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Bo Ahrén, Ole Torffvit, Stig Attvall, Magnus Ekelund, Karin Filipsson, Bengt-Olov Tengmark, Stefan Sjöberg, Nils-Gunnar Pehrsson
BMJ (Clinical research ed.) - 2015 -
Excess Mortality among Persons with Type 2
Diabetes
Mauro Tancredi, Annika Rosengren, A. M. Svensson, M. Kosiborod, A. Pivodic, Soffia Gudbjörnsdottir, H. Wedel, M. Clements, S. Dahlqvist, Marcus Lind
New England Journal of Medicine - 2015 -
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide
trial)
Marcus Lind, I. B. Hirsch, J. Tuomilehto, S. Dahlqvist, B. Ahren, O. Torffvit, Stig Attvall, M. Ekelund, K. Filipsson, B. O. Tengmark, S. Sjoberg, N. G. Pehrsson
Bmj-British Medical Journal - 2015 -
Decreased eGFR as a risk factor for heart failure in 13,781 patients with type 1
diabetes
Daniel Vestberg, Annika Rosengren, Marita Olsson, Soffia Gudbjörnsdottir, Börje Haraldsson, A. M. Svensson, Marcus Lind
Diabetologia. 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). Stockholm, Sverige, 14-18 september 2015. - 2015 -
Recognition of Incident Diabetes Mellitus During an Acute Myocardial
Infarction
S. V. Arnold, J. M. Stolker, K. J. Lipska, P. G. Jones, J. A. Spertus, D. K. McGuire, S. E. Inzucchi, A. Goyal, T. M. Maddox, Marcus Lind, D. Gumber, S. Shore, M. Kosiborod
Circulation-Cardiovascular Quality and Outcomes - 2015 -
Predicting the Effectiveness of Insulin Pump Therapy on Glycemic Control in Clinical Practice: A Retrospective Study of Patients with Type 1 Diabetes from 10 Outpatient Diabetes Clinics in Sweden over 5
Years
M. Clements, Viktorija Matuleviciene, Stig Attvall, M. Ekelund, A. Pivodic, S. Dahlqvist, M. Fahlen, Börje Haraldsson, Marcus Lind
Diabetes Technology & Therapeutics - 2015 -
Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide
trial)
Marcus Lind, I. B. Hirsch, J. Tuomilehto, S. Dahlqvist, O. Torffvit, N. G. Pehrsson
PRIMARY CARE DIABETES - 2015 -
The association between BMI and hospitalization for heart failure in 83 021 persons with Type 2 diabetes: a population-based study from the Swedish National Diabetes
Registry
S. Glogner, Annika Rosengren, Marita Olsson, Soffia Gudbjörnsdottir, A. M. Svensson, Marcus Lind
Diabetic Medicine - 2014 -
The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial
infarction
S. V. Arnold, K. J. Lipska, S. E. Inzucchi, Y. Li, P. G. Jones, D. K. McGuire, A. Goyal, J. M. Stolker, Marcus Lind, J. A. Spertus, M. Kosiborod
BMJ Open Diabetes Research and Care - 2014 -
Age at diagnosis predicts deterioration in glycaemic control among children and adolescents with type 1
diabetes
M. A. Clements, Marcus Lind, S. Raman, S. R. Patton, K. J. Lipska, A. G. Fridlington, F. Tang, P. G. Jones, Y. Wu, J. A. Spertus, M. Kosiborod
BMJ Open Diabetes Research and Care - 2014 -
A retrospective study in 5,989 patients with type 1 diabetes in 10 outpatient diabetes clinics in Sweden of the frequency of measuring HbA1c in clinical
practice
Viktorija Matuleviciene, Stig Attvall, M Ekelund, M Clements, S Dahlqvist, M Fahlén, A Pivodic, Börje Haraldsson, Marcus Lind
Journal of Diabetes & Metabolism - 2014 -
The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for
Diabetes
Marcus Lind, J. Tuomilehto, M. Uusitupa, Olle Nerman, J. Eriksson, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, M. Peltonen, A. Pivodic, J. Lindstrom
PLoS ONE - 2014 -
Glycemic control and excess mortality in type 1
diabetes
Marcus Lind, A.M. Svensson, M.N. Kosiborod, Soffia Gudbjörnsdottir, A. Pivodic, H. Wedel, S. Dahlqvist, M.A. Clements, Annika Rosengren
New England Journal of Medicine - 2014 -
A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1
Diabetes
Viktorija Matuleviciene, J. I. Joseph, M. Andelin, I. B. Hirsch, Stig Attvall, A. Pivodic, S. Dahlqvist, D. Klonoff, Börje Haraldsson, Marcus Lind
Diabetes Technology & Therapeutics - 2014 -
Changes in HbA(1c) and frequency of measuring HbA(1c) and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the
UK
Marcus Lind, A. Pivodic, L. Cea-Soriano, Olle Nerman, N. G. Pehrsson, L. A. Garcia-Rodriguez
Diabetologia - 2014 -
Assessment of well-being in diabetes: A Comparison of MLP with back-propagation and support vector
regression
MR NarasingaRAO, TM Padmaja, GR Sridhar, Marcus Lind, K Madhu, V Ramakrishna
Journal of Life Medicine - 2013 -
Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: A population-based study from the Swedish National Diabetes
Registry
Daniel Vestberg, Annika Rosengren, Marita Olsson, Soffia Gudbjörnsdottir, A. M. Svensson, Marcus Lind
Diabetes Care - 2013 -
The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2
trial
L. G. Mellbin, K. Malmberg, L. Ryden, H. Wedel, D. Vestberg, Marcus Lind
European Heart Journal - 2013 -
Temporal trends and hospital variation in the management of severe hyperglycemia among patients with acute myocardial infarction in the United
States
L. Venkitachalam, D. K. McGuire, K. Gosch, K. Lipska, S. E. Inzucchi, Marcus Lind, A. Goyal, J. A. Spertus, F. A. Masoudi, P. G. Jones, M. Kosiborod
American heart journal - 2013 -
Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based
study
Marcus Lind, Luis A. Garcia Rodriguez, G. L. Booth, L. Cea-Soriano, B. R. Shah, G. Ekeroth, L. L. Lipscombe
Diabetologia - 2013 -
Insulin Pump-Long-Term Effects on Glycemic Control: An Observational Study at 10 Diabetes Clinics in
Sweden
Britt-Marie Carlsson, Stig Attvall, M. Clements, S. R. Gumpeny, A. Pivodic, L. Sternemalm, Marcus Lind
Diabetes Technology & Therapeutics - 2013 -
Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial
fibrillation.
Marcus Lind, Martin Fahlén, Mikhail Kosiborod, Björn Eliasson, Anders Odén
Thrombosis research - 2012 -
Time-dependent relatonship between HbA1c and subsequent death or myocardial infarction may explain the UKPDS legacy
effect.
Marcus Lind, A Odén, R Coleman, Olle Nerman, R Holman
American Diabetes Association 72nd Scientific Sessions (2012), 8-12 Juni, Philadelphia. - 2012 -
The relationship between glycaemic control and heart failure in 83,021 patients with type 2
diabetes
Marcus Lind, Marita Olsson, Annika Rosengren, A. M. Svensson, I. Bounias, Soffia Gudbjörnsdottir
Diabetologia - 2012 -
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with
diabetes.
Marcus Lind, Martin Fahlén, Björn Eliasson, Anders Odén
Primary care diabetes - 2012 -
Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment
satisfaction
Marcus Lind, J. Jendle, O. Torffvit, I. Lager
Primary Care Diabetes - 2012 -
Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial
infarction
J. M. Stolker, J. A. Spertus, D. K. McGuire, Marcus Lind, F. Tang, P. G. Jones, S. E. Inzucchi, S. S. Rathore, T. M. Maddox, F. A. Masoudi, M. Kosiborod
Diabetes Care - 2012 -
Availability of insulin pump therapy in clinical
practice
Britt-Marie Carlsson, P. N. Andersson, J. Alnervik, J. Carstensen, Marcus Lind
Diabetic Medicine - 2012 -
Incretin therapy and its effect on body weight in patients with
diabetes
Marcus Lind
Primary Care Diabetes - 2012 -
Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical
practice
J. Anderson, S. Attvall, L. Sternemalm, A. Pivodic, M. Fahlen, R. Hanas, G. Ekeroth, Marcus Lind
Journal of diabetes science and technology - 2011 -
Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational
study
Marcus Lind, I. Bounias, Marita Olsson, Soffia Gudbjörnsdottir, A. M. Svensson, Annika Rosengren
Lancet - 2011 -
Cure of psoriasis and arthritis when Addison´s disease was
detected
Marcus Lind
Case Rep Dermatol - 2010 -
The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c
variables
Marcus Lind, Anders Odén, M. Fahlen, Björn Eliasson
PLoS ONE - 2009 -
The effect of insulin lispro on glycemic control in a large patient
cohort.
Marcus Lind, Martin Fahlén, Michael Happich, Anders Odén, Björn Eliasson
Diabetes technology & therapeutics - 2009 -
Glycaemic control: evaluation of HbA1c as a risk factor and the effect of modern insulins in clinical
practice
Marcus Lind
2009